Maureen Oconnell

CIK 1111318 · EVP, CAO & CFO · last filed 2026-09-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.83M

Companies

Total Filings

Lifetime Open-Market Net

-$19.96M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

SCHL price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

ACACIA RESEARCH CORP — 15 joint filings, latest 2026-09-04

TEREX CORP — 4 joint filings, latest 2026-06-30

BARNES & NOBLE INC — 2 joint filings, latest 2001-07-10

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ACTG	Director	254,655	$4.20	$1.07M	-$103.6K	12	2026-09-04
TEX	Director	16,351	$52.62	$860.4K	$0	2	2026-03-09
REV Group, Inc. (REVG) Delisted	Director	2,105	$63.90	$134.5K	$0	5	2026-02-02
HHS	Director	25,414	$4.37	$110.9K	$0	3	2020-09-02
Sucampo Pharmaceuticals, Inc. (SCMP) Delisted	Director	0	—	—	$0	6	2018-02-13
SCHL	EVP, CAO & CFO	71,771	$38.94	$2.79M	-$19.86M	68	2017-09-26

Recent Filings · Page 7 of 10

97 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2013-12-30	SCHL	Sell (S)	−20,000	-$672.8K	EDGAR
2013-10-08	SCHL	Tax (F)	−1,785	-$50.2K	EDGAR
2013-09-19	SCHL	Grant (A)	+6,960	$210.0K	EDGAR
2013-09-05	SCHL	Mixed	+5,544	$169.8K	EDGAR
2013-08-29	SCHL	Tax (F)	−1,150	-$34.4K	EDGAR
2013-07-23	SCHL	Tax (F)	−1,941	-$57.1K	EDGAR
2013-05-30	Sucampo Pharmaceuticals, Inc. (SCMP) Delisted	Grant (A)	—	$0	EDGAR
2013-03-08	Sucampo Pharmaceuticals, Inc. (SCMP) Delisted	Grant (A)	—	$0	EDGAR
2012-10-10	SCHL	Tax (F)	−1,568	-$52.7K	EDGAR
2012-10-03	SCHL	Mixed	—	-$213.4K	EDGAR

Showing 61–70 of 97

Prev Page 7 of 10 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.